In an effort to combat high prescription drug costs, legislators included language in the Consolidated Appropriations Act, 2021, requiring group health plans to submit detailed information about prescription drug pricing and health care spending to the federal government. The submission form is known as the “RxDC report.”

In late 2020, the Departments of Health and Human Services, Labor, and Treasury released the Transparency in Coverage Final Rules (TIC) and the Consolidated Appropriations Act (CAA) was signed into law. These two initiatives provide new consumer protections as described below, and include extensive transparency reforms intended

Pinnacle Claims Management Health Plan Transparency Pinnacle is committed to our clients, and as such, we actively work to ensure you receive the necessary guidance as it pertains to legislative changes in health care. There have been several provisions of the Consolidated Appropriations Act of 2021 (CAA)

On January 10, 2022, the Biden Administration announced that, beginning January 15, individuals with private health insurance coverage or covered by a group health plan who purchase an over-the-counter COVID test authorized, cleared, or approved by the U.S. Food and Drug Administration (FDA) will be able to

Dear Valued Clients, On December 27, 2020, President Trump signed Consolidated Appropriations Act, 2021 (“Act”). The voluminous appropriations and COVID-19 relief package also includes the most significant health care legislation since the Affordable Care Act, addressing balancing billing and cost transparency, as well as extending the COVID-related

Q&A with Debbie Bellenger, Manager of Health and Wellness, Pinnacle Health Management Health and wellness benefits are evolving because of COVID-19. An estimated 57% of senior leaders are assigning a higher priority to care benefits to better support employees’ work/life balance due to the pandemic, according to

FAQs  (Updated May 25, 2021) Subsidy Eligibility Q:  What would disqualify a termed employee from being eligible for the subsidy? A:  The subsidy is available to assistance eligible individuals (AEIs)—qualified beneficiaries who are eligible for and elect COBRA for a period of coverage within the subsidy period

This resource provides an overview of a specific federal and state developments. It is subject to change and is not intended to be, and should not be construed as, legal advice for any particular situation. You can read the attachment here, or review the text below. Last

While the country is still in the early phases of distributing the COVID-19 vaccine, we want to keep you informed of what we are doing as an organization to prepare. As you are aware, the COVID-19 vaccine will have limited availability at first due to limited supplies.